Analysis of the TCGA-AML cohort revealed low TRIM6 expression in patients with AML, and both univariate and multivariate Cox regression analyses identified low TRIM6 expression as a poor prognostic factor for survival. This evidence concerns the gene TRIM6 and acute myeloid leukemia.